Tumor cell clearance reimagined.
Our mission is to discover, translate, and deliver pioneering curative cell therapies that incorporate multiple forms of tumor clearance into single T cells.
CERs explained
Our technology uniquely integrates anti-tumor capabilities of both the innate and adaptive immune systems into a single T cell.
› Exploiting a Natural Immune Process
The CER platform
We are advancing a CER T-cell platform that offers novel approaches for the treatment of both hematologic malignancies and solid tumors.
› Therapeutic Potential of Our Platform
Join the quest
Our culture is mission-and innovation-driven towards bringing improved treatment options to patients. We are looking for talented and motivated individuals to join us in our quest.
› Careers at CERo
A differentiated mechanism of action for solid tumors
We are excited to announce new clinical data on CER T cell activity in NSCLC presented at Society of Immunotherapy of Cancer (SITC) 2022.
› Download PosterNews and events
May 02, 2022
CERo Therapeutics’ Multifunctional CER T Cells Synergize with Standard of Care Small Molecule Anti-Tumor Inhibitors Across Hematologic and Solid Tumor ModelsNov 12, 2021
CERo Therapeutics’ Novel Chimeric Engulfment Receptor T Cells Exhibit Multifunctional Properties and Enhanced Tumor KillingOct 25, 2021
CERo to Present at the Society of Immunotherapy for Cancer (SITC)